High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children

Insights

Screening overweight children for impaired glucose tolerance (IGT) can be improved. Elevated blood pressure and liver enzymes are key indicators, increasing the predictability of IGT in pediatric populations.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Debate exists on optimal screening criteria for impaired glucose tolerance (IGT) in overweight and obese children.
  • Oral glucose tolerance testing (OGTT) is used for diagnosis, but identifying high-risk individuals is crucial.

Purpose of the Study:

  • To identify risk factors that predict the presence of IGT in overweight children.
  • To evaluate the effectiveness of combining screening parameters for improved IGT detection.

Main Methods:

  • A cohort of overweight children undergoing OGTT was analyzed.
  • Association of anthropometric and laboratory parameters with IGT was determined.
  • The sensitivity of screening for IGT using combined parameters was assessed.

Main Results:

  • Out of 145 children, 11 had IGT, with two also having impaired fasting glucose (IFG).
  • Elevated blood pressure (p=0.025) and elevated liver enzymes (p=0.003) were significantly associated with IGT.
  • Screening based on elevated blood pressure or liver enzymes achieved a sensitivity of 1.00 for IGT detection.

Conclusions:

  • Screening overweight children with elevated blood pressure or elevated liver enzymes significantly enhances IGT predictability.
  • Combining these parameters improves IGT screening compared to using IFG alone.
  • This approach offers a more sensitive method for identifying children at risk for IGT.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
336
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K